Pricing

Log inSign up

Synklino

1 follower
‌

Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

Industries

Health Care, Biotechnology

Headquarters

Lyngby, Denmark

Employees

11-50

Links

Org chart

Thomas Kledal
CEO & Co-Founder
Collapse
Jette Wagtberg Sen
COO
Carit Jacques Andersen
CFO
Dagmar Fæster Kildedal
Industrial Phd Student
IM
Ian McGowan
Chief Medical Officer

Board & advisors

Mette Rosenkilde
Co-Founder & Board Member
John Haurum
Chairman
Morten Schrøder
Board Member
Magnus Persson
Board Member
Thomas Feldthus
Board Member
Christine Flarup Møller-Jensen
Board Member
Mads Lacoppidan
Board Member
John Sinclair
Scientific Advisor
John Lambert
Scientific Advisor
Atul Humar
Scientific Advisor

Similar companies

Bavarian Nordic

9 followers

Tango Therapeutics

3 followers

Merck

303 followers

Cellares

5 followers

Function Health

12 followers

Revvity

12 followers

Visma Dinero

32 followers

Sanofi

328 followers

Gilead Sciences

174 followers

Regeneron

144 followers

AtriCure

4 followers

Explore companies